Following post-stroke, immediate treatment with SHH pathway agonists significantly increased the expression of vasculogenesis-related factors including VEGF, FGF and ANG, together with SHH signaling proteins PTCH1, GLI 1, GLI 2 and SMO. Here, SHH is linked to stroke disorder.